Apr 11, 2019Breakthrough Cancer Therapy Developer, Alpha Tau, Awarded ISO 13485 Certificate for Quality ManagemeAlpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy, Alpha DaRT, announced today that it has obtained ISO...
Mar 26, 2019Cancer Biotech Firm Alpha Tau Medical Appoints Raphi Levy of Goldman Sachs as Chief Financial OfficeTel Aviv, Israel, March 26, 2019 – Alpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy, Alpha DaRT, announced...
Nov 7, 2018Alpha Tau Medical Launches New Clinical Trials in Italy with Leading Cancer Centers, La Sapienza andTrials will investigate the efficacy of its breakthrough cancer treatment, Alpha DaRT, in Squamous Cell Carcinoma (SCC) of the Skin, and...
Sep 5, 2018Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure CancerProceeds to accelerate expansion of global clinical research program and establish new production facilities to meet growing demand for...
Aug 22, 2018Alpha Tau’s High-Precision Cancer Radiotherapy Receives Radioactive-Safety Approval in the United StThe new Sealed Source and Device (SSD) approval enables the commencement of clinical trials in leading hospitals across the U.S. with the...